One attractive hypothesis is that these changes might arise from Tau-mediated disruption of axonal transport, leading to impaired delivery of mitochondria and synaptic vesicles and resulting in terminal collapse, consistent with prior observations in a variety of Tauopathy models [17, 26, 38]. The gene discussed is MAPT; the disease is tauopathy.